Loading [MathJax]/jax/output/HTML-CSS/fonts/TeX/fontdata.js

Journal List > Korean J Pediatr Infect Dis > v.21(1) > 1096029

Park, Kim, Chun, Lee, Kim, and Kang: Clinical Manifestations, Management, and Natural Course of Infants with Recurrent Bronchiolitis or Reactive Airways Disease

Abstract

Purpose

The purpose of this study was to investigate the clinical manifestations and 5-year natural course of recurrent bronchiolitis or reactive airways disease (RAD) in infants.

Methods

We reviewed the medical records of infants with recurrent bronchiolitis from January 2007 to December 2007 at The Catholic University of Korea St. Mary's Hospital in Incheon, South Korea. Additionally, we telephoned their parents to confirm their present medical statuses.

Results

Sixty-three subjects with recurrent bronchiolitis were identified. The mean age at admission was 8.1 months and the number of males was 44 (69.8%). Of the 63 infants with recurrent bronchiolitis, inhaled corticosteroids, bronchodilators, and antibiotics were given to 62 (98.4%), 53 (84.1%), and 40 (63.5%), respectively. Among the total 63 subjects, we were able to contact the parents of 45 children by telephone. None of these children had been hospitalized during the previous one year period due to respiratory infections or for other medical reasons. Of the 45 subjects we were able to contact, 38 (84.4%) had not experienced any further respiratory difficulties at all. Five (11.1%) had been diagnosed with allergic rhinitis while two (4.4%) were being managed for asthma.

Conclusion

Most children who presented with recurrent episodes of bronchiolitis in infancy did not show any further respiratory difficulties after five years of age.

Figures and Tables

kjpid-21-37-g001
Fig. 1
Five-year follow-up (natural course) of recurrent bronchiolitis or reactive airways disease (RAD) in infants was described. Most children (84.4%) who presented with recurrent episodes of bronchiolitis in infancy did not show any further respiratory difficulties after five years of age.

Download Figure

Table 1
Clinical Manifestations of Infants with Recurrent Bronchiolitis
kjpid-21-37-i001

*defined as attendance at day care center and/or number of family members ≥5.

≥5.0 mg/dL.

Abbreviations: WBC, white blood cell; CRP, C-reactive protein.

Download Table

Table 2
Comparison of the Inpatient Management of Acute Bronchiolitis by Country
kjpid-21-37-i002

*not available.

Download Table

References

1. Watts KD, Goodman DM. Wheezing, Bronchiolitis, and Bronchitis. In : Kliegman RM, Behrman RE, Jenson HB, Stanton BE, editors. Nelson Textbook of Pediatrics. 18th ed. Philadelphia: WB Saunders Co;2007. p. 1773–1778.
2. Kim MR, Lee HR, Lee GM. Epidemiology of acute viral respiratory tract infections in Korean children. J Infect. 2000; 41:152–158.
crossref
3. Welliver RC. Bronchiolitis and infectious asthma. In : Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplam SL, editors. Textbook of pediatric infectious diseases. 6th ed. Philadelphia: WB Saunders Co;2009. p. 277–288.
4. Fisher RG. Bronchiolitis and wheezing. In : Fisher RG, Boyce TG, editors. Moffet's pediatric infectious diseases. 4th ed. Philadelphia: WB Saunders Co;2005. p. 156–166.
5. Wang EE, Law BJ, Boucher FD, Stephens D, Robinson JL, Dobson S, et al. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1996; 129:390–395.
crossref
6. Barben J, Hammer J. Current management of acute bronchiolitis in Switzerland. Swiss Med Wkly. 2003; 133:9–15.
7. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics. 2006; 118:1774–1793.
8. Carraro S, Zanconato S, Baraldi E. Bronchiolitis: from empiricism to scientific evidence. Minerva Pediatr. 2009; 61:217–225.
9. Hubble D, Osborn GR. Acute Bronchiolitis in Children. Br Med J. 1941; 1:107–126.
crossref
10. Leer JA Jr, Green JL, Heimlich EM, Hyde JS, Moffet HL, Young GA. Corticosteroid treatment in bronchiolitis. A controlled, collaborative study in 297 infants and children. Am J Dis Child. 1969; 117:495–503.
11. Suh DI, Koh YY. Early childhood wheezing: various natural courses and their relationship to later asthma. Korean J Pediatr. 2012; 55:259–264.
crossref
12. Ahn K, Kim J, Kwon HJ, Chae Y, Hahm MI, Lee KJ, et al. The prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in Korean children: Nationwide cross-sectional survey using complex sampling design. J Korean Med Assoc. 2011; 54:769–778.
crossref
13. King VJ, Viswanathan M, Bordley WC, Jackman AM, Sutton SF, Lohr KN, et al. Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Arch Pediatr Adolesc Med. 2004; 158:127–137.
crossref
14. Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2013; 6:CD004878.
crossref
15. Wright M, Piedimonte G. Respiratory syncytial virus prevention and therapy: past, present, and future. Pediatr Pulmonol. 2011; 46:324–347.
crossref
16. Barben J, Kuehni CE, Trachsel D, Hammer J. Swiss Paediatric Respiratory Research Group. Management of acute bronchiolitis: can evidence based guidelines alter clinical practice? Thorax. 2008; 63:1103–1109.
crossref
17. McCulloh RJ, Smitherman SE, Koehn KL, Alverson BK. Assessing the impact of national guidelines on the management of children hospitalized for acute bronchiolitis. Pediatr Pulmonol;2013. in press.
18. Johnson LW, Robles J, Hudgins A, Osburn S, Martin D, Thompson A. Management of bronchiolitis in the emergency department: impact of evidence-based guidelines? Pediatrics. 2013; 131:Suppl 1. S103–S109.
crossref
TOOLS
Similar articles